Coreva Scientific assesses the CaRi-Heart technology for NICE
- National Institute for Health and Care Excellence
- North West
- Direct
- 2 January 2026 to 31 December 2026
The National Institute for Health and Care Excellence (NICE) hired Coreva Scientific to assess the CaRi-Heart technology. CaRi-Heart aims to predict cardiac risk among patients with suspected coronary artery disease.
Coreva Scientific works as an External Assessment Group (EAG) on a mini Rapid Update Assessment (RUA). The firm weighs the clinical evidence and how well the software predicts risk, to inform NICE guidance.
NICE awarded the £99,440 contract directly, without a tender. The work runs from January to December 2026.
Contract ends December 2026
- What
- Health economics and health technology assessment
- Supplier
- Coreva Scientific
- Value
- £99,440
- How it was bought
- Direct
- Dates and next
- Jan 2026 to Dec 2026